Wird geladen...
Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
This retrospective cohort study evaluated the risk of prostate cancer associated with sitagliptin use in Taiwanese male patients with type 2 diabetes mellitus by using the reimbursement databases of the National Health Insurance. Male patients with newly diagnosed type 2 diabetes mellitus at an age...
Gespeichert in:
| Veröffentlicht in: | Oncotarget |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Impact Journals LLC
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386669/ https://ncbi.nlm.nih.gov/pubmed/27661113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12137 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|